2016 Annual Meeting of the Association for Vision and Resear
Billed as "the largest gathering of eye and vision researchers in the world," the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) will provide opportunities for attendees to explore cutting-edge science and collaborate with their peers.
Randy Kardon from the University of Iowa: Studying Vision Loss in Veterans to Learn More for Civilian Care
Henry Kaplan from University of Louisville School of Medicine: Combatting Retinal Degeneration with Glucose
According to Henry Kaplan, MD, University of Louisville School of Medicine, "One has to recognize that there are multiple approaches like gene therapy, neuroprotection, stem cell transplantation, and pharmacologic manipulation of other genes really holds the greatest benefit in terms of trying to reverse the inevitable loss of vision."
Bevacizumab Produces Long-Term Regression of Retinal Neovascularization in Proliferative Diabetic Retinopathy
After 12 or 24 monthly injections, ranibizumab, one of three currently available vascular endothelial growth factor antibodies, caused regression of diabetic retinopathy (DR) in at least 75% of patients who had diabetic macular edema and whose DR severity put them at the highest risk of progression to proliferative DR.